The thorniest questions facing pharma, according to a leading bioethicist
PharmaVoice
NOVEMBER 6, 2023
Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.
Bioethics Related Topics 
246 
Opinion: Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
STAT
AUGUST 11, 2024
As executive director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, my work includes legal, ethical, and policy analysis surrounding psychedelic medicine. But if lessons from reproductive health are any signal, I believe there is a future for psychedelics in health care.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The essential biotech updates of the day
STAT
SEPTEMBER 16, 2024
Today, we talk about bioethics, catch up on some reports from ESMO, and wonder aloud and in print over a surprising liquid biopsy bet. The need-to-know this morning Ascendis Pharma reported positive results from a Phase 3 study of Transcon CNP in children with achondroplasia, the most common form of dwarfism.
STAT+: Venture capitalists want to own hospitals. Can they do better than private equity?
STAT
NOVEMBER 1, 2023
Given workforce shortages, clinician burnout, rising drug costs, and a surging aging population, “it’s not that big a leap to say that more such purchases are going to occur,” said Robert Klitzman, a Columbia psychiatry professor and director of its bioethics masters program.
Bioethics International reveals index to score pharma on trial diversity
Outsourcing Pharma
JANUARY 12, 2023
The not-for-profit organization published its fair inclusion score to measure and rank pharmaceutical companies on their inclusion of women, older adults, and racial and ethnic minoritized patients.
STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug
STAT
MARCH 6, 2023
”It’s imprudent and unwise and not the way forward, even for people who are very ill,” said Dr. Arthur Caplan, a professor of bioethics at the NYU Langone hospital system in New York who chaired a university panel that studied the FDA’s compassionate use program.
Bayer Pharmaceuticals accelerates innovations for patients
LifeProNow
MARCH 27, 2023
Bayer works on leveraging all the possibilities of the technologies while fully integrating all regulatory and bioethical requirements.” ” [link] The post Bayer Pharmaceuticals accelerates innovations for patients appeared first on LifeProNow.
Let's personalize your content